Method for in vitro diagnosis or prognosis of colon cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11453916
APP PUB NO 20140349857A1
SERIAL NO

14367526

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for in vitro diagnosis or prognosis of colon cancer, including a step of detecting at least one expression product of at least one HERV nucleic acid sequence, the use of said isolated nucleic acid sequences as a molecular marker/molecular markers, and a kit including at least one specific binding partner for at least one expression product of the HERV nucleic acid sequences.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOMERIEUX69280 MARCY L'ETOILE
HOSPICES CIVILS DE LYON69229 LYON CEDEX 02

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mallet, François Villeurbanne, FR 21 10
Mugnier, Nathalie Lyons, FR 6 10
Perot, Philippe Lyons, FR 12 12

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 27, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 27, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 27, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00